EVIDITY CAPITAL LLC
MIAMI, FLORIDA

EVIDITY CAPITAL LLC serves as a vital arm of Canepa Healthcare, LLC, a firm recognized by Florida authorities for its influential operations in venture capital targeting medical technology advancements. Headquartered at 1111 Brickell Avenue in Miami, Evidity plays an essential role within the group's mission to nurture late-stage private companies poised to revolutionize patient care through enhanced product offerings. Since its incorporation on January 2, 2015, it operates under the identifier M15000000042 and is accessible via canepahealthcare.com. Originally known as CANEPA HEALTHCARE, LLC until May 23, 2019, Evidity Capital is focused on empowering healthcare businesses that are ready to scale. By investing in companies with regulatory approvals either from the U.S. or Europe, it enables rapid revenue growth and operational expansion over a span of three to five years. The firm specializes in injecting value into firms requiring at least $5 million in additional funding. Whether choosing controlling or minority roles, Evidity's involvement is hands-on and dedicated to enriching its portfolio companies. With their core focus on medical devices and diagnostics-without excluding sub-sectors-the company targets markets with substantial clinical needs backed by compelling data and strong economic value propositions. They prioritize investment in enterprises led by top-tier management teams capable of navigating the complexities of the healthcare industry. In the broader scope, Canepa Healthcare itself innovates within ophthalmic medical devices aiming to improve near vision using cutting-edge pinhole technology. This tech underlies notable products like the KAMRA® corneal inlay and the IC-8® intraocular lens. As of their latest update on April 13, 2024, Evidity continues to progress under the strategic oversight of co-managers Alejandro Sanchez and Paul Enever, ensuring alignment with Canepa's overarching goals.